COLR:EURONEXT BRUSSELSColruyt Group N.V. Analysis
Data as of 2026-03-12 - not real-time
€34.07
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Colruyt Group trades at €34.07, exactly matching its 20‑day SMA and identified support level, indicating a price floor that may hold in the near term. The technical picture shows a bearish trend direction, yet the MACD histogram is positive and the MACD signal line has turned bullish, hinting at a possible short‑term rebound. Volatility remains elevated at ~24.6% over the past 30 days, while beta is exceptionally low, suggesting the stock moves largely independently of broader market swings. On the fundamentals side, revenue is growing at 4.5% annually and the company maintains a respectable gross margin of 29%, but operating margins are thin at 4% and free cash flow is negative, raising questions about cash generation. The dividend yield stands out at 4.05% with a payout ratio of 56%, offering income appeal but the negative free cash flow flags sustainability concerns. Valuation is the most compelling driver: the DCF‑derived fair value of €53.29 is about 57% above the current price, implying a sizable upside potential. The defensive consumer‑staple sector and diversified business lines—from grocery to renewable energy—provide a stable backdrop, yet low trading volume and limited analyst coverage add liquidity risk. Overall, the stock appears undervalued with a strong dividend, but short‑term price action may be constrained by technical weakness and cash‑flow pressures.
Investors should weigh the attractive valuation and income versus the liquidity constraints and cash‑flow challenges when deciding on positioning.
Investors should weigh the attractive valuation and income versus the liquidity constraints and cash‑flow challenges when deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish trend direction with price anchored at support
- Positive MACD histogram suggesting limited upside
- Low trading volume increasing execution risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value ~57% above market price
- Steady revenue growth and defensive sector positioning
- Attractive dividend yield despite cash‑flow concerns
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term valuation gap and potential for price re‑rating
- Diversified business model into energy and health services
- Low beta and defensive consumer‑staple exposure
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin2.62%
P/E Ratio13.8
ROE9.52%
ROA3.86%
Debt/Equity29.43
P/B Ratio1.3
Op. Cash Flow€597.9M
Free Cash Flow€-361962496
Technical Analysis
TrendBearish
RSI51.1
Support€34.07
Resistance€34.07
MA 20€34.07
MA 50€34.49
MA 200€36.83
MACDBullish
VolumeStable
Fear & Greed Index74.77
Valuation
Fair Value€53.29
GradeUndervalued
TypeBlend
Dividend Yield4.05%
Risk Assessment
Beta0.02
Volatility24.58%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.